BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8032345)

  • 1. Role of differentiation induction in action of purine antimetabolites.
    Weber G; Hata Y; Prajda N
    Pharm World Sci; 1994 Apr; 16(2):77-83. PubMed ID: 8032345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical issues in chemotherapy with tiazofurin.
    Weber G
    Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
    Weber G; Nagai M; Natsumeda Y; Eble JN; Jayaram HN; Paulik E; Zhen WN; Hoffman R; Tricot G
    Cancer Commun; 1991 Mar; 3(3):61-6. PubMed ID: 1705812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of de novo and salvage pathways in chemotherapy.
    Weber G; Nagai M; Natsumeda Y; Ichikawa S; Nakamura H; Eble JN; Jayaram HN; Zhen WN; Paulik E; Hoffman R
    Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways].
    Szekeres T; Fritzer M; Schön HJ; Findenig G; Lhotka C
    Wien Klin Wochenschr; 1994; 106(14):459-63. PubMed ID: 7941593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E
    Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
    Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted and non-targeted actions of anti-cancer drugs.
    Weber G; Prajda N
    Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiazofurin decreases Ras-GTP complex in K562 cells.
    Hata Y; Natsumeda Y; Weber G
    Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
    Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
    Ban J; Weber G
    Biochem Biophys Res Commun; 1992 Apr; 184(2):551-9. PubMed ID: 1349474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of GTP biosynthesis.
    Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
    Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
    Szekeres T; Schuchter K; Chiba P; Ressmann G; Lhotka C; Gharehbaghi K; Szalay SM; Pillwein K
    Biochem Pharmacol; 1993 Dec; 46(11):1903-7. PubMed ID: 7903533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
    Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.